GLP-1, RhGLP-1 (Recombinant Human GLP-1), and ProGLP-1 (Long Acting GLP-1RA) Because GLP-1 receptors are expressed in the CNS and GLP-1 has also been revealed to play a protective role in cerebral ischemia, GLP-1 may be a promising drug for stroke
Lim J, Heo J, Ju H, Shin JW, Kim Y, Lee S, Yu HY, Ryu CM, Yun H, Song S, Hong KS, Chung HM, Kim HR, Roe JS, Choi K, Kim IG, Jeong EM, Shin DM
Additional at-risk groups include: Vegans and strict vegetarians , who may have low dietary B12 intake People with autoimmune conditions , including pernicious anaemia or type 1 diabetes Individuals with gastrointestinal conditions such as Crohn's disease or coeliac disease, which impair nutrient absorption People who have undergone bariatric surgery , which can significantly reduce B12 absorption Long-term users of proton pump inhibitors (PPIs) or H2-receptor antagonists , which reduce gastric acid and impair B12 release from food Those with a family history of either pernicious anaemia or diabetes For these groups, simultaneous monitoring of B12 status and glycaemic markers is particularly important to avoid diagnostic errors
Patients should feel comfortable discussing any side effects they experience, including skin sensitivity
The lawsuit claims these conditions led to her death in August 2024
| Are Research Peptides Legal